Skip to content

Maha N. Mian

13 papers in the library · 118 citations · publishing 2019-2025

Papers

Sort Most recent Most cited

Investigating Safety Concerns and Harm Reduction in Entheogenic Churches: The Case for Community-Based Participatory Research.

Current Topics in Behavioral Neurosciences November 22, 2025 Maha N. Mian, Allison R. Coker, Grace Kretzer et al.

Alongside the important contributions of the harm reduction movement to improving public health in secular settings, communities that use psychedelics as religious sacraments (i.e., entheogens) have developed their own frameworks for supporting safety within their spiritual practices and hold their own conceptualizations of risk and harm. In order to understand better the lived realities of...

Latent Classes of Lifetime Use of Seven Hallucinogens in the United States

Journal of Psychoactive Drugs August 4, 2025 Meredith C Meacham, Maha N. Mian, Ralph C. Wang et al. 2 citations

Interest in and use of hallucinogens appears to be growing in the United States, yet less is known about the use of multiple hallucinogens. The aims of this study are to characterize subgroups of lifetime hallucinogen use and to identify sociodemographic correlates of these subgroups. Latent class models were fit using 2021-2022 National Survey on Drug Use and Health (NSDUH) data on a...

Social Workers' Attitudes and Beliefs about MDMA-Assisted Therapy for Adolescents with PTSD.

Social Work April 1, 2025 Maha N. Mian, Jordan Horan, Taweh Hunter et al. 1 citation

Given the widespread interest and ongoing study on MDMA-assisted therapy (MDMA-AT) for PTSD, its implications for unique populations-such as adolescents-require further understanding. Social workers will likely play a crucial role in the potential implementation of this intervention, but their perspectives remain unknown. The study includes 222 social workers randomized to read one of two...

Development of the Protective Strategies for Psychedelics Scale: A novel inventory to assess safety strategies in the context of psychedelics

Journal of Psychopharmacology December 4, 2023 Maha N. Mian, Brianna R. Altman, Fiona Low et al. 8 citations

Background: Individuals who use psychedelics take efforts to mitigate unintended consequences. Despite the demonstrated utility of analogous protective behavioral strategies (PBS) assessments for other substances, no standardized scale exists to capture these protective strategies for psychedelic use. Objective: The present study addresses a notable gap concerning the assessment of psychedelic...

Expectancies for Subjective and Antidepressant Effects in Psilocybin Users

Journal of Humanistic Psychology September 22, 2023 Mitch Earleywine, Maha N. Mian, Joseph A. de Leo 5 citations

Expectancy effects for many psychoactive substances appear to play a role in consumption, problematic use, subjective responses to acute administration, and subsequent effects. Expectancies of psychedelics have received little attention in published research despite their reputation for creating dramatic changes in subjective state. Psilocybin-assisted treatment (PAT) improves depression, but...

Expectancies for Cannabis-Induced Emotional Breakthrough, Mystical Experiences and Changes in Dysfunctional Attitudes: Perceptions of the Potential for Cannabis-Assisted Psychotherapy for Depression

Cannabis July 11, 2022 Mitch Earleywine, Maha N. Mian, Brianna R. Altman et al. 11 citations

Psychedelic-assisted psychotherapy has established antidepressant effects. Cannabis users appear to expect high doses administered in a session much like psychedelic-assisted psychotherapy to create comparable subjective effects. The current studies explored expectations of antidepressant effects of such cannabis-assisted sessions to replicate and extend previous work. Users not only expected a...

Cannabis’s Link to Schizotypy: Phenomenon, Measurement Bias, or Delusion?

Cannabis July 11, 2022 Brianna R. Altman, Mitch Earleywine, Maha N. Mian et al.

Links between cannabis use and psychosis generate research and media attention. Cannabis users have outscored non-users on the Schizotypal Personality Questionnaire-Brief (SPQ-B) in multiple studies, but previous work suggests that groups do not differ if biased items are removed. The present study examined links between schizotypal personality and cannabis use in a large sample recruited from...

Symptom specificity of ayahuasca's effect on depressive symptoms

Journal of Psychedelic Studies April 19, 2021 Cody Gilbert, Mitch Earleywine, Maha N. Mian et al. 3 citations

Abstract Background Ayahuasca's effects on symptoms of depression have generated considerable optimism. Clients frequently report more concern about some symptoms than others, and available treatments alter symptoms differentially. Few studies address the symptom specificity of this psychoactive brew. Aims We examined self-reported effects of ayahuasca on the individual symptoms of depression...

Cannabis-induced oceanic boundlessness

Journal of Psychopharmacology March 28, 2021 Mitch Earleywine, Luna F. Ueno, Maha N. Mian et al. 36 citations

Background: Despite tetrahydrocannabinol (THC)’s reputation for creating dramatic effects at high doses, empirical work rarely addresses cannabis’s impact on subjective responses common to the tryptamine psychedelics. We focused on these effects because they have preceded and covaried with the therapeutic impact of psilocybin in previous work. Aims: The current study examined if self-reported...

The Novelty of Ayahuasca Scale and the prediction of intentions to use

Journal of Psychedelic Studies March 12, 2020 Brianna R. Altman, Maha N. Mian, Mitch Earleywine 4 citations

Abstract Objective Given the growing popularity of ayahuasca and other hallucinogens, we sought to identify related expectancies and their role in why people might use this psychoactive brew rather than classic hallucinogens like LSD or psilocybin. Method Experienced users (N = 139) completed an online survey about their use of hallucinogens (including ayahuasca), how their ayahuasca...

Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness

Journal of Psychoactive Drugs September 30, 2019 Maha N. Mian, Brianna R. Altman, Mitch Earleywine 47 citations

Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on changes in mindfulness. This study investigated whether both mindfulness and...

Ayahuasca's antidepressant effects covary with behavioral activation as well as mindfulness

2019 Maha N. Mian

Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on observed changes in mindfulness. The present study investigated if both...